- Home
- FF vs TVGN Comparison
FF vs TVGN Comparison
Compare FF & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- TVGN
- Stock Information
- Founded
- FF N/A
- TVGN 2020
- Country
- FF United States
- TVGN United States
- Employees
- FF 537
- TVGN N/A
- Industry
- FF Major Chemicals
- TVGN Blank Checks
- Sector
- FF Industrials
- TVGN Finance
- Exchange
- FF Nasdaq
- TVGN Nasdaq
- Market Cap
- FF 180.0M
- TVGN 193.1M
- IPO Year
- FF N/A
- TVGN N/A
- Fundamental
- Price
- FF $4.07
- TVGN $1.09
- Analyst Decision
- FF Strong Buy
- TVGN Strong Buy
- Analyst Count
- FF 1
- TVGN 1
- Target Price
- FF $0.80
- TVGN $10.00
- AVG Volume (30 Days)
- FF 282.3K
- TVGN 1.6M
- Earning Date
- FF 05-12-2025
- TVGN 05-28-2025
- Dividend Yield
- FF 5.93%
- TVGN N/A
- EPS Growth
- FF N/A
- TVGN N/A
- EPS
- FF 0.35
- TVGN N/A
- Revenue
- FF $243,339,000.00
- TVGN N/A
- Revenue This Year
- FF N/A
- TVGN N/A
- Revenue Next Year
- FF N/A
- TVGN N/A
- P/E Ratio
- FF $11.40
- TVGN N/A
- Revenue Growth
- FF N/A
- TVGN N/A
- 52 Week Low
- FF $3.77
- TVGN $0.26
- 52 Week High
- FF $6.40
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- FF 49.58
- TVGN 53.96
- Support Level
- FF $3.91
- TVGN $1.01
- Resistance Level
- FF $4.19
- TVGN $1.09
- Average True Range (ATR)
- FF 0.13
- TVGN 0.08
- MACD
- FF 0.01
- TVGN 0.02
- Stochastic Oscillator
- FF 62.50
- TVGN 94.74
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.